What Does Menthol Do to Your Lungs?

Menthol triggers a cold-sensing receptor in your airways that makes breathing feel easier and suppresses the urge to cough, but it does not actually open your airways or improve airflow. That sensory trick is the starting point for a range of downstream effects, some briefly helpful during a cold and others genuinely harmful when menthol is inhaled repeatedly through cigarettes or e-cigarettes. Lab and animal studies show menthol can slow mucus clearance, ramp up lung inflammation, damage the protective coating inside your air sacs, and stress lung cells at a molecular level. The picture depends heavily on how you’re inhaling menthol, how much, and how often.

How Menthol Tricks Your Airways Into Feeling Cool

Menthol doesn’t lower the temperature inside your nose or lungs. It activates a protein called TRPM8, the same ion channel your body uses to detect actual cold. When TRPM8 fires, your brain interprets the signal as coolness even though nothing has changed thermally.¹ This is why a menthol cough drop or a dab of vapor rub under the nose creates an immediate sensation of open, clear breathing.

The cooling signal also dials down irritation reflexes. Research on airway sensory nerves shows that TRPM8 activation by menthol can suppress the hypersensitivity of C-fibers, the nerve endings that trigger coughing and the feeling of throat tightness when exposed to irritants like cigarette smoke.² In other words, menthol doesn’t remove the irritant. It turns down the alarm your nerves would normally sound in response.

A review of how plant-derived substances affect respiratory receptors found that menthol’s cough-suppressing benefit stems largely from TRPM8 activation in the nasal passages rather than deep in the lungs. The cooling sensation you notice in your nose and throat does most of the heavy lifting for that “I can breathe again” feeling.³

The Illusion of Better Airflow

One of the most persistent misconceptions about menthol is that it acts as a decongestant, physically widening your nasal passages or bronchial tubes. Multiple controlled studies say otherwise. A randomized crossover study in healthy adults measured upper airway resistance before and after menthol inhalation and found no change.⁴ An earlier study measuring nasal resistance reached the same conclusion: menthol vapor did not reduce resistance to airflow, even though the majority of subjects reported a sensation of improved breathing.⁵

This disconnect between what people feel and what instruments measure is consistent. In a study where subjects breathed against added resistance, nasal menthol inhalation cut the perceived discomfort of labored breathing by roughly 40 percent during one type of loading, without changing the actual breathing pattern or ventilation at all.⁶ A separate study found that almost all participants reported improved nasal breathing after menthol inhalation, again purely from cold-receptor stimulation rather than any measurable change in the airway.⁷

For someone congested with a cold, that perceptual relief is real and can be genuinely comforting. But it means menthol is not treating the underlying swelling or mucus buildup. And in other contexts, such as smoking, this same illusion becomes a liability rather than a benefit.

Mucus Clearance Takes a Hit

Your airways are lined with tiny hair-like structures called cilia that beat in coordinated waves to push mucus, trapped particles, and pathogens up and out of your lungs. This conveyor belt is called mucociliary clearance, and it is one of your lungs’ most important defense systems. Menthol appears to impair it.

A 2023 study using lab-grown human airway tissue found that menthol exposure significantly slowed the beat frequency of cilia and reduced the volume of the thin fluid layer that sits on top of airway cells and keeps mucus moving. Menthol also increased the production of a thick type of mucus protein and raised the expression of inflammatory signaling molecules. These effects were tied directly to TRPM8 activation, because blocking that receptor with a specific antagonist prevented them.⁸

The practical implication is straightforward: if menthol slows the system that clears debris and pathogens from your airways, inhaling it repeatedly could leave your lungs more vulnerable to infection and irritant buildup. This is a lab finding, not a clinical trial in living people, so translating it directly to real-world risk requires caution. But it suggests that the same receptor responsible for the pleasant cooling sensation is also the doorway for mucus-related harm.

Menthol in Cigarettes and Why It Matters

The combination of menthol and cigarette smoke is where the science gets especially concerning. A key laboratory finding is that menthol acts as a potent counterirritant against the harsh chemicals in tobacco smoke. At concentrations even lower than what is present in a mentholated cigarette, menthol immediately abolished the irritation response to acrolein, one of the most irritating components of smoke. Blocking TRPM8 reversed this effect, confirming the mechanism.⁹

This counterirritant effect is a double-edged sword. By masking the harshness of smoke, menthol makes inhaling deeply more tolerable, which can make cigarettes easier to start with and harder to quit. The tobacco industry has long marketed menthol cigarettes partly on this “smoothness,” and the sensory evidence backs up why they feel smoother even though the underlying toxicant exposure is the same or worse.

A mouse study comparing menthol cigarette smoke to non-menthol cigarette smoke over a week of exposure found that menthol smoke caused more severe lung inflammation. The menthol-smoke-exposed mice had greater activation of inflammatory signaling pathways and worse tissue damage on microscopic examination. When researchers blocked TRPM8, the excess inflammation from menthol smoke largely disappeared, and the remaining inflammatory response was similar between the two smoke types.¹⁰ That finding is striking: it implies the added inflammation from menthol cigarettes is not from some unique chemical cocktail but is driven through the very same cooling receptor that makes the smoke feel mild.

Whether this translates into worse outcomes for human smokers is harder to pin down, but there’s suggestive clinical data. An analysis from the COPDGene cohort, a large study of smokers with and without chronic obstructive pulmonary disease, found that menthol cigarette smokers had roughly 29 percent higher odds of experiencing a severe COPD flare-up compared with non-menthol smokers.¹¹ This is a single observational finding and not proof of causation, but it aligns with the animal evidence suggesting menthol amplifies smoking-related lung damage.

The data on whether menthol changes how people physically smoke, such as puff volume and inhalation depth, are inconsistent. Some studies suggest deeper inhalation; others find no difference. Researchers have acknowledged that methodological issues make it hard to draw firm conclusions on this question.¹² The clearer concern is the biological one: menthol suppresses the warning signals your lungs would otherwise use to tell you something is wrong, and it may directly amplify the inflammatory response to smoke through TRPM8.

Menthol in E-Cigarettes and Vaping

Menthol is one of the most popular flavoring agents in e-cigarettes, and the assumption that vaping is gentler on the lungs than smoking has led many users to overlook menthol’s specific effects in aerosol form. The evidence here is still mostly from laboratory studies, but the findings are not reassuring.

A study exposing precision-cut lung slices, thin sections of actual lung tissue that preserve much of the organ’s architecture, to menthol-flavored e-cigarette condensate found dose-dependent damage to cells. Menthol-containing condensates impaired mitochondrial energy production through both major metabolic pathways the cells rely on. The researchers described the results as demonstrating “prominent menthol-induced pulmonary toxicity.”¹³

Other lab work has found that menthol increases the production of damaging reactive oxygen species inside the mitochondria of human bronchial epithelial cells, triggers inflammatory signaling through pathways involving NF-κB and cytokines like IL-6 and IL-8, and activates antioxidant stress responses, all hallmarks of tissue injury.¹⁴ Similar findings emerged from a separate group that detected elevated mitochondrial protein oxidation and upregulated oxidative stress and inflammatory pathways after menthol exposure in three-dimensional airway tissue models.¹⁵

An important caveat: these are cell and tissue studies, not evidence from people who vape over months or years. But the consistency of findings across different labs and different experimental approaches builds a worrying picture. Menthol is not simply inert flavoring carried along for the ride in e-cigarette vapor. It is biologically active in lung tissue at the concentrations delivered by vaping devices.

Damage to the Protective Coating of Air Sacs

Deep inside your lungs, the tiny air sacs where oxygen enters your blood are coated with a thin film called pulmonary surfactant. This film is critical: it reduces surface tension so the air sacs can inflate and deflate smoothly with each breath. Without functional surfactant, breathing becomes enormously difficult, which is why surfactant failure is a major problem in conditions like acute respiratory distress syndrome.

Menthol appears to interfere with this surfactant. A study exposing bovine surfactant to e-cigarette aerosols found that menthol-flavored aerosol raised the minimum surface tension of the surfactant more than any other flavor tested, across all compression-expansion cycles. In plain terms, the surfactant stopped doing its job as effectively.¹⁶ Researchers found that this inhibition appears to come from menthol interacting directly with both the fat molecules and the proteins that make up the surfactant film.¹⁷

A systematic comparison of eight e-cigarette flavoring chemicals confirmed the effect was flavor-dependent, with menthol among the most disruptive.¹⁸ These findings remain in the realm of bench science, but surfactant impairment is not a subtle problem. Even modest reductions in surfactant function can increase the work of breathing and reduce gas exchange efficiency over time.

How the Body Processes Inhaled Menthol

When you inhale menthol, whether from a cough drop, a cigarette, or a vaping device, it doesn’t just act locally and disappear. Menthol enters the bloodstream, where the liver converts it to menthol glucuronide, a water-soluble form the body can excrete. Plasma concentrations of this metabolite rise in a dose-dependent fashion after inhalation.¹⁹

This matters because it means the lungs are not the only organ exposed. The systemic absorption also provides researchers with a measurable biomarker to track how much menthol a person has actually taken in, which is useful for studying dose-response relationships in smokers and vapers. For the average user, the key takeaway is that menthol does not stay in the airways. It circulates, gets metabolized, and is cleared, but whatever damage it does at the airway surface has already occurred by the time clearance happens.

Synthetic Coolants in Vaping Products

Many e-cigarette liquids advertise a menthol or “ice” sensation but actually contain synthetic cooling compounds like WS-3 and WS-23 rather than natural menthol. These chemicals activate similar cold receptors but have far less safety data behind them. A chemical analysis of popular U.S.-market e-liquids and disposable vaping devices found WS-3 in nearly all refill liquids tested and WS-23 in almost every variety of a popular disposable brand. When researchers modeled the daily intake from typical vaping behavior, the margin of exposure fell below safe thresholds for most use scenarios.²⁰

These synthetic coolants are approved for use in food at low levels, but the safety data for repeated inhalation simply does not exist in any meaningful quantity. The lungs are not the digestive tract. Chemicals that pass safely through the gut may behave very differently when deposited directly onto delicate airway and alveolar tissue. For vapers who choose “ice” or “cool” flavors assuming they are safer than menthol, the reality is that these alternatives may carry comparable or even less well-understood risks.

Short-Term Relief Versus Long-Term Risk

The duality of menthol in the lungs comes down to context and duration. A menthol cough drop during a cold exploits the TRPM8 cooling illusion to make congested breathing feel more comfortable. The exposure is brief, the concentration is low, and the relief, while perceptual rather than physical, can help someone rest and recover. That’s a reasonable trade-off for most healthy adults, and it’s why menthol has been a staple of over-the-counter cold remedies for over a century.

The risks escalate with chronic, high-concentration exposure through smoking or vaping. In those contexts, menthol suppresses the warning cues that might otherwise prompt someone to inhale less deeply or quit sooner, impairs the mucus-clearing system that protects the lungs from accumulated debris, triggers inflammatory cascading through the same receptor responsible for the cooling sensation, degrades pulmonary surfactant, and inflicts measurable oxidative stress and cell damage. None of these effects requires menthol to be uniquely toxic on its own. What makes it dangerous is how effectively it masks the harm being done while simultaneously contributing to it.

People with asthma should be particularly cautious. Although TRPM8 activation can initially reduce the sensation of airway tightness, animal and cell data suggest that repeated menthol exposure could worsen underlying airway inflammation and impair the clearance mechanisms asthmatic lungs already struggle with. The comfortable feeling of menthol can be misleading for someone whose airways are already prone to hyperreactivity.

Why Menthol Cigarettes Have Drawn Regulatory Attention

The U.S. Food and Drug Administration proposed banning menthol as a characterizing flavor in cigarettes, a move that has been debated for years. The scientific rationale rests on two pillars. First, the counterirritant properties of menthol lower the barrier to starting smoking and make quitting harder, because the sensory punishment that normally discourages deep inhalation is muted.⁹ Second, the emerging evidence that menthol actively worsens lung inflammation through TRPM8-mediated pathways suggests the additive is not merely cosmetic. It changes the biology of how smoke interacts with lung tissue.¹⁰

Menthol cigarettes have disproportionately been marketed to certain communities, and the public health stakes of a ban extend well beyond the biochemistry. But from a purely lung-focused standpoint, the case is clear enough: menthol does not make cigarettes safer. It makes them feel safer, which may be worse.